CI Canadian Convertible Bond ETF Common (TSE:CXF - Get Free Report)'s share price rose 0.7% during mid-day trading on Monday . The stock traded as high as C$10.37 and last traded at C$10.32. Approximately 4,900 shares were traded during trading, an increase of 16% from the average daily volume of 4,241 shares. The stock had previously closed at C$10.25.
CI Canadian Convertible Bond ETF Common Stock Performance
The company has a fifty day moving average price of C$10.22 and a 200-day moving average price of C$10.09.
CI Canadian Convertible Bond ETF Common Company Profile
(
Get Free Report)
Chimerix, Inc, a biopharmaceutical company, develops medicines to enhance the lives of patients living with serious diseases. The company's approved product is TEMBEXA (brincidofovir), a lipid conjugate through inhibition of viral DNA synthesis that is developed as a medical countermeasure for smallpox.
Further Reading
Before you consider CI Canadian Convertible Bond ETF Common, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and CI Canadian Convertible Bond ETF Common wasn't on the list.
While CI Canadian Convertible Bond ETF Common currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Enter your email address and we'll send you MarketBeat's list of seven stocks and why their long-term outlooks are very promising.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
MarketBeat All Access